Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)

China flag China · Delayed Price · Currency is CNY
6.58
+0.03 (0.46%)
Apr 29, 2026, 3:00 PM CST
-8.74%
Market Cap 6.69B
Revenue (ttm) 3.68B
Net Income (ttm) 168.94M
Shares Out 1.02B
EPS (ttm) 0.16
PE Ratio 41.10
Forward PE 27.80
Dividend 0.06 (0.87%)
Ex-Dividend Date n/a
Volume 5,313,362
Average Volume 6,382,841
Open 6.54
Previous Close 6.55
Day's Range 6.51 - 6.63
52-Week Range 6.38 - 9.42
Beta 1.25
RSI 38.89
Earnings Date Apr 3, 2026

About SHA:600223

Lushang Freda Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of cosmetics, pharmaceuticals, raw materials, and additives in China. It is involved in property management services. The company provides facial cleansers, lotions, creams, sprays, masks, and other products. It also offers products in the field of dermatology, orthopedics, ophthalmology, gynecology, and pediatrics, respiratory, endocrinology, andrology, tonic, and plasters, as well as hyaluronic acid and its derivatives, bio-fermentation, plant ex... [Read more]

Sector Real Estate
Founded 1993
Employees 3,514
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600223
Full Company Profile

Financial Performance

In 2025, SHA:600223's revenue was 3.65 billion, a decrease of -8.33% compared to the previous year's 3.98 billion. Earnings were 187.75 million, a decrease of -22.90%.

Financial Statements

News

There is no news available yet.